サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339173

アプタマー市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、地域別、セグメント動向、2023年～2032年

Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, Peptide); By Application (Diagnostics, Therapeutics, Research & Developments, Others); By Region, And Segment Forecasts, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アプタマー市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、地域別、セグメント動向、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のアプタマー市場規模は2032年までに163億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

アプタマーの多用途性と、ヘルスケア、バイオテクノロジー、診断などの様々な産業におけるその潜在的な応用は、多くの企業の注目を集めています。さらに、特定のターゲット用にカスタマイズされたアプタマーが利用できるようになったことで、アプタマーの用途は従来の研究や診断での使用以外にも広がっています。このため、治療薬やバイオセンサーなど、アプタマーをベースにした新製品が開発され、アプタマー市場の成長をさらに促進すると期待されています。

SELEX技術は、SARS-CoV-2やCOVID-19に関連する特定のバイオマーカーに結合できるアプタマーの開発に使用されており、診断キットやアッセイの開発を可能にしています。これらのアプタマーベースの診断ツールは、ウイルスや関連バイオマーカーの検出において高い感度と特異性を提供することができ、病気の診断やモニタリングに役立ちます。その結果、このような診断キットやアッセイの市場へのイントロダクションが市場の成長を促進すると予想されます。

2021年12月、Achiko AGのCOVID-19診断キットAptamexがインドネシア保健省から承認を受けた。AptamexはDNAアプタマー技術を用いて開発された第2世代のキットで、費用対効果が高く、化学合成された医薬品の診断キットです。

市場の成長は、米国FDA、カナダ保健省、EMA、COFEPRIS、MHRA、CDSCOなど、この分野の研究開発を支援するイニシアチブを取っている様々な規制機関によってさらに支えられています。例えば、2020年3月、米国FDAはIVERIC Bio社のZimuraをAMDに続発する地理的萎縮症（GA）患者の治療薬としてFast Track指定しました。これはペグ化RNAアプタマーで、合成され、硝子体内注射によって投与されます。AMD発症の原因とされるC5因子を阻害することで作用します。

アプタマー市場レポートハイライト

診断、治療、バイオマーカー探索の急速な進展により、核酸分野が市場を独占

研究開発分野は、アプタマー製造企業への関心の高さと政府の積極的な取り組みにより、市場シェアで上位を占めました。

診断分野は、病気の早期診断のためのアプタマーベースの診断キットのニーズの高まりにより、最も速い成長率を記録しました。

北米は、アプタマー開発に従事する企業の存在と、科学的ブレークスルーのための強力な産学連携により、最大のシェアを獲得しました。

アジア太平洋は、大規模な患者プールの存在、膨大な未開拓人口、研究に対する政府の有利な政策により、高い成長率を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のアプタマー市場に関する洞察

  • アプタマー市場- 業界スナップショット
  • アプタマー市場力学
    • 促進要因と機会
      • 抗体に対するアプタマーの利点の増加
      • 慢性疾患や希少疾患の有病率の上昇
    • 抑制要因と課題
      • アプタマー調査へのベンチャーキャピタル資金の増加
  • PESTLE分析
  • アプタマー業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のアプタマー市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 核酸アプタマー
  • ペプチドアプタマー

第6章 世界のアプタマー市場、用途別

  • 主な調査結果
  • イントロダクション
  • 診断
  • 治療学
  • 研究開発
  • その他

第7章 世界のアプタマー市場、地域別

  • 主な調査結果
  • イントロダクション
    • アプタマー市場評価、地域別、2019-2032年
  • アプタマー市場-北米
    • 北米：アプタマー市場、用途別、2019-2032年
    • 北米：アプタマー市場、タイプ別、2019-2032年
    • アプタマー市場-米国
    • アプタマー市場- カナダ
  • アプタマー市場- 欧州
    • 欧州：アプタマー市場、用途別、2019～2032年
    • 欧州：アプタマー市場、種類別、2019～2032年
    • アプタマー市場- 英国
    • アプタマー市場- フランス
    • アプタマー市場- ドイツ
    • アプタマーマーケット-イタリア
    • アプタマー市場- スペイン
    • アプタマーマーケット-オランダ
    • アプタマー市場- ロシア
  • アプタマー市場- アジア太平洋
    • アジア太平洋：アプタマー市場、用途別、2019～2032年
    • アジア太平洋：アプタマー市場、タイプ別、2019～2032年
    • アプタマー市場- 中国
    • アプタマー市場- インド
    • アプタマー市場- マレーシア
    • アプタマー市場- 日本
    • アプタマー市場- インドネシア
    • アプタマー市場- 韓国
  • アプタマー市場-中東およびアフリカ
    • 中東およびアフリカ：アプタマー市場、用途別、2019～2032年
    • 中東およびアフリカ：アプタマー市場、種類別、2019～2032年
    • アプタマー市場- サウジアラビア
    • アプタマー市場- アラブ首長国連邦
    • アプタマー市場- イスラエル
    • アプタマー市場- 南アフリカ
  • アプタマー市場-ラテンアメリカ
    • ラテンアメリカ：アプタマー市場、用途別、2019-2032年
    • ラテンアメリカ：アプタマー市場、タイプ別、2019-2032年
    • アプタマー市場- メキシコ
    • アプタマー市場- ブラジル
    • アプタマー市場- アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Base Pair Biotechnologies
  • SomaLogic
  • Aptadel Therapeutics
  • Aptamer Group
  • Noxxon Pharma
  • Aptagen
  • TriLink Biotechnologies
  • Altermune
  • Vivonics
  • AM Biotechnologies
図表

List of Tables

  • Table 1 Global Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Global Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Aptamers Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 5 North America: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 7 U.S.: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 9 Canada: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Europe: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 13 UK: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 15 France: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 17 Germany: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 19 Italy: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Spain: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Russia: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 29 China: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 31 India: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Japan: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 39 South Korea: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 45 UAE: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Israel: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 49 South Africa: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Latin America: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Mexico: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Brazil: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Aptamers Market, by Application, 2019-2032 (USD Billion)
  • Table 57 Argentina: Aptamers Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Aptamers Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Aptamers Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Aptamers Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Aptamers Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Aptamers Market
目次
Product Code: PM3553

The global aptamers market size is expected to reach USD 16.33 billion by 2032, according to a new study by Polaris Market Research. The report "Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, and Peptide); By Application (Diagnostics, Therapeutics, Research & Developments, and Others); By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Versatility of aptamers and their potential applications in various industries such as healthcare, biotechnology, and diagnostics have attracted the attention of many companies. Moreover, the availability of customized aptamers for specific targets has expanded the applications of aptamers beyond their traditional use in research and diagnostics. This has led to the development of new aptamer-based products, including therapeutics and biosensors, which are expected to further drive the growth of the aptamers market.

The SELEX technology has been used to develop aptamers that can bind to specific biomarkers related to SARS-CoV-2 and COVID-19, allowing for the development of diagnostic kits and assays. These aptamer-based diagnostic tools can provide high sensitivity and specificity in detecting the virus and related biomarkers, which can aid in disease diagnosis and monitoring. As a result, the introduction of such diagnostic kits and assays in the market is expected to drive the growth of the market.

In December 2021, Achiko AG's Aptamex, a COVID-19 diagnostic kit, received approval from the health ministry of Indonesia. Aptamex is a 2nd generation kit developed using DNA aptamer technology, which is cost-effective, chemically synthesized, diagnostic kit in the pharmaceuticals.

Market growth is further supported by various regulatory agencies such as the U.S. FDA, Health Canada, EMA, COFEPRIS, MHRA, & CDSCO, which have taken initiatives to support the research and development in this field. For example, in March 2020, the U.S. FDA granted Fast Track designation to IVERIC Bio's Zimura for the treatment of patients with geographic atrophy (GA) secondary to AMD. It is a pegylated RNA aptamer, which is synthesized & administered by the intra-vitreal injection. It works by the inhibition of factor C5, considered responsible for onset of AMD.

Aptamers Market Report Highlights

Nucleic acid segment dominated the market, owing to rapid development in the diagnostics, therapeutics, and advancements in the biomarker discovery

R&D segment accounted for the larger market share, as there is a strong interest in aptamer manufacturing companies, and favorable government initiatives

Diagnostic segment recorded fastest growth rate, owing to rising need for aptamer based diagnostic kits for the early disease diagnosis

North America garnered the largest share, owing to the presence of companies engaged in the development of aptamers, and strong industry academia collaboration for scientific breakthroughs

Asia Pacific is projected to register a higher growth rate, owing to the presence of large patient pool, huge untapped population, and favorable government policies for research.

The global players include: Base Pair Biotechnologies, SomaLogic, Aptadel Therapeutics, Aptamer Group, Noxxon Pharma, Aptagen, TriLink Biotechnologies, Altermune, Vivonics, and AM Biotechnologies.

Polaris Market Research has segmented the aptamers market report based on type, application, and region:

Aptamers, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Nucleic Acid Aptamer
  • Peptide Aptamer

Aptamers, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Diagnostics
  • Therapeutics
  • Research and Development
  • Others

Aptamers, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Aptamers Market Insights

  • 4.1. Aptamers Market - Industry Snapshot
  • 4.2. Aptamers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising number of the advantages of aptamers over antibodies
      • 4.2.1.2.Rising prevalence of chronic and rare disease
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Growth in the venture capital funding for research on aptamers
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Aptamers Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Aptamers Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Aptamers, by Type, 2019-2032 (USD Billion)
  • 5.3. Nucleic Acid Aptamer
    • 5.3.1. Global Aptamers Market, by Nucleic Acid Aptamer, by Region, 2019-2032 (USD Billion)
  • 5.4. Peptide Aptamer
    • 5.4.1. Global Aptamers Market, by Peptide Aptamer, by Region, 2019-2032 (USD Billion)

6. Global Aptamers Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Aptamers Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Diagnostics
    • 6.3.1. Global Aptamers Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
  • 6.4. Therapeutics
    • 6.4.1. Global Aptamers Market, by Therapeutics, by Region, 2019-2032 (USD Billion)
  • 6.5. Research and Development
    • 6.5.1. Global Aptamers Market, by Research and Development, by Region, 2019-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Aptamers Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Aptamers Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Aptamers Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Aptamers Market - North America
    • 7.3.1. North America: Aptamers Market, by Application, 2019-2032 (USD Billion)
    • 7.3.2. North America: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Aptamers Market - U.S.
      • 7.3.3.1. U.S.: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Aptamers Market - Canada
      • 7.3.4.1. Canada: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Aptamers Market - Europe
    • 7.4.1. Europe: Aptamers Market, by Application, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Aptamers Market - UK
      • 7.4.3.1. UK: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Aptamers Market - France
      • 7.4.4.1. France: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Aptamers Market - Germany
      • 7.4.5.1. Germany: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Aptamers Market - Italy
      • 7.4.6.1. Italy: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Aptamers Market - Spain
      • 7.4.7.1. Spain: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Aptamers Market - Netherlands
      • 7.4.8.1. Netherlands: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Aptamers Market - Russia
      • 7.4.9.1. Russia: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Aptamers Market - Asia Pacific
    • 7.5.1. Asia Pacific: Aptamers Market, by Application, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Aptamers Market - China
      • 7.5.3.1. China: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Aptamers Market - India
      • 7.5.4.1. India: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Aptamers Market - Malaysia
      • 7.5.5.1. Malaysia: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Aptamers Market - Japan
      • 7.5.6.1. Japan: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Aptamers Market - Indonesia
      • 7.5.7.1. Indonesia: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Aptamers Market - South Korea
      • 7.5.8.1. South Korea: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Aptamers Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Aptamers Market, by Application, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Aptamers Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Aptamers Market - UAE
      • 7.6.4.1. UAE: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Aptamers Market - Israel
      • 7.6.5.1. Israel: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Aptamers Market - South Africa
      • 7.6.6.1. South Africa: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Aptamers Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Aptamers Market - Latin America
    • 7.7.1. Latin America: Aptamers Market, by Application, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Aptamers Market - Mexico
      • 7.7.3.1. Mexico: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Aptamers Market - Brazil
      • 7.7.4.1. Brazil: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Aptamers Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Aptamers Market - Argentina
      • 7.7.5.1. Argentina: Aptamers Market, by Application, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Aptamers Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Base Pair Biotechnologies
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. SomaLogic
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Aptadel Therapeutics
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Aptamer Group
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Noxxon Pharma
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Aptagen
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. TriLink Biotechnologies
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Altermune
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Vivonics
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. AM Biotechnologies
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development